Vanda Pharmaceuticals Inc. (VNDA) key performance indicators and operating metrics (5 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Fanapt Net Product Sales | 29.6M | FY2026-Q1 |
| Hetlioz Net Product Sales | 15.9M | FY2026-Q1 |
| Ponvory Net Product Sales | 6.2M | FY2026-Q1 |
| Total Net Product Sales | 51.7M | FY2026-Q1 |
| Fanapt Total Prescriptions Growth | 36.00 percent | FY2025-Q4 |
Back to VNDA overview · VNDA earnings · VNDA holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.